Loading...
Recherche

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

Laboratoire de recherches Intégratives en Neurosciences et psychologie Cognitive UR-LINC   →  The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
ts-blog-classic-datebox-overlay{ display:none; }